Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-29

Clinical Trial Update: Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing CHF 1535 to Beclomethasone and a free combination therapy in asthmatic children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beclomethasone Dipropionate (beclomethasone dipropionate)
  • CHF 1535
  • Free Combination Therapy

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED